Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study | Zendy

Matthew E. Falagas | Zendy; Petros I. Rafailidis | Zendy; Diamantis P. Kofteridis | Zendy; Simona Virtzili | Zendy; Fotini C Chelvatzoglou | Zendy; Vassiliki Papaioannou | Zendy; Sofia Maraki | Zendy; George Samonis | Zendy; Argyris Michalopoulos | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study

Author(s) -

Matthew E. Falagas,

Petros I. Rafailidis,

Diamantis P. Kofteridis,

Simona Virtzili,

Fotini C Chelvatzoglou,

Vassiliki Papaioannou,

Sofia Maraki,

George Samonis,

Argyris Michalopoulos

Publication year - 2007

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkm356

Subject(s) - klebsiella pneumoniae , carbapenem , klebsiella infections , klebsiella , microbiology and biotechnology , medicine , enterobacteriaceae , carbapenem resistant enterobacteriaceae , antibacterial agent , antibiotics , biology , escherichia coli , gene , biochemistry

Carbapenems are frequently used to treat infections due to extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Thus, the emergence of infections due to carbapenem-resistant K. pneumoniae (CRKp) is a major public health concern.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research